Story excerpt provided by Crain’s Cleveland Business.
Written by Chuck Soder.
George Soros is doubling down on Abeona Therapeutics.
The Cleveland company — which is developing treatments designed to reverse rare genetic diseases — just raised $8.5 million from a few of its existing investors and board members.
One of them is Soros Fund Management, a fund founded by the iconic billionaire. Abeona also raised cash from Perceptive Life Science Fund and two of its board members.
Click here to read the complete article.
Originally published July 28, 2015.